Provided by Tiger Trade Technology Pte. Ltd.

Milestone Pharmaceuticals Inc.

1.20
-0.0100-0.83%
Post-market: 1.210.0100+0.83%19:52 EDT
Volume:1.59M
Turnover:1.94M
Market Cap:148.80M
PE:-1.78
High:1.26
Open:1.21
Low:1.20
Close:1.21
52wk High:3.06
52wk Low:1.00
Shares:124.00M
Float Shares:106.47M
Volume Ratio:1.40
T/O Rate:1.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6748
EPS(LYR):-0.7517
ROE:-35522.62%
ROA:-42.78%
PB:8.17
PE(LYR):-1.60

Loading ...

Canada's Milestone Pharmaceuticals Q1 revenue misses estimates after CARDAMYST launch

Reuters
·
May 13

Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 13

Milestone Pharmaceuticals Q1 Revenue USD 238 Thousand VS. Ibes Estimate USD 37.6 Million

THOMSON REUTERS
·
May 13

Milestone Pharma Q1 net loss widens 25.6% to $26.07 million

Reuters
·
May 13

Milestone Pharmaceuticals Q1 EPS $(0.20) Misses $0.14 Estimate, Sales $238.000K

Benzinga Earnings
·
May 13

Milestone Pharmaceuticals Inc expected to post earnings of 31 cents a share - Earnings Preview

Reuters
·
May 11

Milestone Pharmaceuticals to report Q1 2026 results, host investor call

Reuters
·
May 06

Milestone Pharmaceuticals announces annual shareholder meeting

Reuters
·
May 01

Milestone Pharma CEO Joseph Oliveto disposes of 36,500 shares for $82,490

Reuters
·
Apr 21

Milestone launches Phase 4 RESET-PSVT registry for CARDAMYST nasal spray in adults

Reuters
·
Apr 10

Milestone Pharmaceuticals Announces Reset-Psvt Registry to Generate Real-World Evidence on Cardamyst™ (Etripamil) Nasal Spray in Patients With Psvt

THOMSON REUTERS
·
Apr 10

Milestone Pharma to Present at Needham Virtual Healthcare Conference

Reuters
·
Apr 07

Milestone Pharmaceuticals grants 123,000 inducement stock options to new hires

Reuters
·
Apr 02

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Apr 02

Milestone says Express Scripts adds CARDAMYST to commercial national formularies

Reuters
·
Apr 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (SNY), Milestone Pharmaceuticals (MIST) and Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Mar 31

Milestone Pharmaceuticals files Form 3 for GC and Chief Compliance Officer David I. Sandoval

Reuters
·
Mar 24

Regulatory Disruptions Pose Material Operational Risks for Milestone Pharmaceuticals

TIPRANKS
·
Mar 21

Why Milestone Pharma Stock Is Taking A Dive Today

Benzinga Earnings
·
Mar 20

Milestone Pharmaceuticals Q4 EPS $(0.16), Inline, Sales $1.546M Beat $1.200M Estimate

Benzinga Earnings
·
Mar 20